Market Overview:

The global nucleic acid isolation and purification market size reached US$ 4.45 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.47 Billion by 2027, exhibiting a growth rate (CAGR) of 8.80% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Nucleic acid isolation and purification are routine procedures in molecular biology and forensic analysis. They are used for separating deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from proteins, membranes, and other cellular materials through reagent-based and column-based techniques. Hair, blood, bones, sperm, saliva, nails, and urine are some of the commonly used sources for nucleic acid isolation and purification. They assist clinicians in processing the samples in minimum time, diagnosing patients with genetic mutations, determining the high risk for cancer, developing new therapeutics, and enhancing the effectiveness of drugs. As a result, these techniques are extensively employed in various verticals, including bioscience research, gene-splicing, molecular diagnostics, pharmaceuticals, and forensics.

Nucleic Acid Isolation and Purification Market Trends:

The increasing employment of the procedure in pharmaceutical and biotechnological industries across the globe represents one of the key factors driving the market growth. Nucleic acid isolation and purification are used to identify microorganisms and genetic predispositions, detect different mutations, and determine their role in antibiotics. In line with this, the increasing prevalence of infectious diseases, genetic disorders, and chronic conditions, such as cancer, are favoring the market growth. Apart from this, the introduction of magnetic bead-based extraction kits used for liquid handling platforms that are capable of extracting the highest purity nucleic acids from tissue, blood, and plant materials is providing an impetus to the market growth. Furthermore, the rising awareness about genomic diagnostics among patients and the increasing efficiency of genomics sequencing in diagnosing diseases is acting as another growth-inducing factor. Additionally, the widespread utilization of DNA and RNA isolation for screening and detecting pathogens and microorganisms in routine samples and the rapid adoption of polymerase chain reaction (PCR) techniques to detect genetic abnormalities are supporting the market growth. Other factors, including the significant improvements in the healthcare infrastructure and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleic acid isolation and purification market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, type, method and end user.

Breakup by Product:

• Kits and Reagents
• Instruments
   

Breakup by Type:

• Plasmid DNA Isolation and Purification
• Total RNA Isolation and Purification
• Circulating Nucleic Acid Isolation and Purification
• Genomic DNA Isolation and Purification
• Messenger RNA Isolation and Purification
• microRNA Isolation and Purification
• PCR Cleanup
• Others
   

Breakup by Method:

• Column-Based Isolation and Purification
• Magnetic Bead-Based Isolation and Purification
• Reagent-Based Isolation and Purification
• Others
   

Breakup by End User:

• Hospitals and Diagnostic Centers
• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Macherey-Nagel Gmbh & Co. Kg, New England Biolabs, Norgen Biotek Corp., Omega Bio-Tek Inc., Promega Corporation, Qiagen, Roche Molecular Systems Inc. (F. Hoffmann-La Roche AG), Takara Bio Inc. (Takara Holdings Inc.) and Thermo Fisher Scientific Inc.

Report Coverage:

Key Questions Answered in This Report:

• How has the global nucleic acid isolation and purification market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global nucleic acid isolation and purification market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the method?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global nucleic acid isolation and purification market and who are the key players?
• What is the degree of competition in the industry?